[1]
S. W. . Gillani, A. Azhar, S. M. Gulam, F. B. Gebreigziabher, and H. A. Rathore, “Comparative efficacy of empagliflozin versus placebo in the treatment of type 1 diabetes mellitus: a meta-analysis of randomized controlled trials”, Curr. Issues Pharm. Med. Sci., vol. 34, no. 3, pp. 123–129, Oct. 2021, doi: 10.2478/cipms-2021-0024.